Roche cuts 300-400 product development work: Swiss newspaper

Zurich-Roche plans to cut 300-400 jobs on its product development (PD) site this year, executives including Chief Medical Officer Levi Garraway said with employees obtained by the Swiss newspaper Brick. Said in a recorded video call.

“We made the difficult decision to reduce PD’s workforce by about 5-7% by the end of the year,” Gallaway said on the phone. “And that’s the equivalent of 300-400 roles that are globally affected.”

Roche employs 101,000 people worldwide.

The Basel-based company confirmed that the video call had taken place and said in a statement that it would work with all employees to mitigate the impact of unemployment.

A Roche spokeswoman said in a Reuters statement: “Based on current assumptions, plans to shift more resources in product development (PD) to new drug development will reduce 300-400 positions worldwide. It could be done. ” “No further decisions have been made at this time.”

Roche has a product development site where employees’ duties include clinical trials of future medicines born from research programs in Switzerland, the United States, the United Kingdom, China and Canada.

Affected jobs include business support positions, including project management, project implementation, learning and development, business management, coaching, and management support, Roche’s manager said in a video call.

Unemployed people will be notified from August to October, first to UK employees and then to employees elsewhere. Their work will end in early November, the HR manager said in a video.

“This is the most difficult thing I have had to do since I was in Roche,” said Felix Allerano, Global Drug Safety Officer, in a recording.

Roche posted a net profit of CHF 15.1 billion ($ 16.3 billion) in 2020 as the pandemic diagnosis helped reduce drug sales.

John Miller

Posted on